Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
APTOF
$1.69
+0.00%
APTOF
· Aptose Biosciences Inc.
$1.69
+0.00 (+0.00%)
At close · Jul 3
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our ability to continue as a going concern; - our need to raise substantial additional capital in the near future and our ability to raise such funds when needed and on acceptable terms; - if a financing is completed, it may not be a large enough financing to fully fund the company's operations”View the 10-Q filed May 13, 2026
Market Cap
$4.31M
Shares
2.55M
All earnings calls
Earnings call · FY2022 Q2
Aptose Biosciences Inc. (APTOF) Q2 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$0
Diluted EPS
-$49.80
Net income
-$10.56M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 2, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 2, 2022 · complete as-filed document